In our study, CD68 immunoreactive microglia (Figure 4L) cultured on top of AD (Figures 4K,M) or control brain sections did not change the total Aβ burden, with or without inhibition of the key regulatory enzymes in the eicosanoid pathway (data not shown). The gene discussed is CD68; the disease is Alzheimer disease.